How can we reduce the global burden of disease?
نویسندگان
چکیده
منابع مشابه
How can we reduce the mortality of invasive pneumococcal disease?
I n this issue of the European Respiratory Review, LUDWIG et al. [1] present an article highlighting the continuous burden caused by invasive pneumococcal disease (IPD). Demographic changes due to the growing elderly population will further increase this problem. Bacterial infections of the upper and lower airways are most frequently caused by pneumococci in both adults and children, and pneumo...
متن کاملHow can we enhance the value of laboratory tests?
Today, the pressures on the healthcare systems for the controlling of the costs are extreme and all sectors try to demonstrate the value of their services by justifying the activities and expenditures so the value can be describe in terms like quality, efficiency, effectiveness, patient satisfaction, cost effectiveness .The value of the lab testing is generally directed to their costs and the c...
متن کاملGlobal surgical initiatives to reduce the surgical burden of disease.
A 12-YEAR-OLD GIRL INVOLVED IN A MOTOR VEHICLE crash is transported to a district hospital in subSaharan Africa with a femur fracture and splenic laceration. Because resources and surgical personnel are limited, resuscitation efforts for the injured girl are inadequate. However, governments, the World Health Organization (WHO), funding agencies, and international nongovernmental organizations (...
متن کاملCan we do something in early life to reduce the risk of obesity?
Obesity usually results from a combination of several modifiable and non-modifiable contributing factors, such as genetics, race, and socioeconomic status. Other factors, including birth by cesarean section, perinatal antibiotics usage, and promotion of exclusive breastfeeding for six months, could be potentially prevented or modulated. However, one of the factors can be easily implemented thro...
متن کاملCan we reduce disease burden from osteoarthritis? An evidence-based priority-setting model
■ The comparison of disparate interventions for the prevention and management of osteoarthritis (OA) is limited by the quality and quantity of published efficacy studies and the use of disparate measures for reporting clinical trial outcomes. ■ The “transfer to utility” technique was used to translate published trial outcomes into a health-related quality-of-life (utility) scale, creating a com...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2015
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(15)00129-4